{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:07:01Z","timestamp":1760144821336,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Nature Science Foundation of China (NSFC)","award":["81971960"],"award-info":[{"award-number":["81971960"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Toxoplasmosis is a significant global zoonosis with devastating impacts, and an effective vaccine against toxoplasmosis for humans has not yet been developed. In this study, we designed and formulated a novel DNA vaccine encoding the inhibitor of STAT1 transcriptional activity (IST) of T. gondii utilizing the eukaryotic expression vector pEGFP-N1 for the first time, with CL264 being a molecular adjuvant. Following intramuscular injection of the vaccine into mice, the levels of antibodies and cytokines were assessed to evaluate the immune response. Additionally, mice were challenged with highly virulent RH-strain tachyzoites of T. gondii, and their survival time was observed. The results show that the levels of IgG in serum, the ratio of IgG2a\/IgG1 and the levels of IFN-\u03b3 in splenocytes of mice were significantly higher in the pEGFP-TgIST group and the pEGFP-TgIST + CL264 group than in the control group. In addition, the proportion of CD4+\/CD8+ T cells was higher in mice immunized with either the pEGFP-TgIST group (p &lt; 0.001) or the pEGFP-TgIST + CL264 group (p &lt; 0.05) compared to the three control groups. Notably, TgIST-immunized mice exhibited prolonged survival times after T. gondii RH strain infection (p &lt; 0.05). Our findings collectively demonstrate that the TgIST DNA vaccine elicits a significant humoral and cellular immune response and offers partial protection against acute T. gondii infection in the immunized mice, which suggests that TgIST holds potential as a candidate for further development as a DNA vaccine.<\/jats:p>","DOI":"10.3390\/vaccines12060577","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:12:27Z","timestamp":1716804747000},"page":"577","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective Efficacy of a Novel DNA Vaccine with a CL264 Molecular Adjuvant against Toxoplasma gondii in a Murine Model"],"prefix":"10.3390","volume":"12","author":[{"given":"Kunping","family":"Ju","sequence":"first","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunnan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9679-5375","authenticated-orcid":false,"given":"Huaiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijpara.2020.11.006","article-title":"Protein kinases in Toxoplasma gondii","volume":"51","author":"Gaji","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41579-021-00518-7","article-title":"Toxoplasma gondii infection and its implications within the central nervous system","volume":"19","author":"Matta","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","first-page":"592","article-title":"Toxoplasmosis as a travel risk","volume":"12 Pt A","year":"2014","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"105016","DOI":"10.1016\/j.micpath.2021.105016","article-title":"GRA8 DNA vaccine formulations protect against chronic toxoplasmosis","volume":"158","author":"Karakavuk","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sun, H.C., Huang, J., Fu, Y., Hao, L.L., Liu, X., and Shi, T.Y. (2021). Enhancing Immune Responses to a DNA Vaccine Encoding Toxoplasma gondii GRA7 Using Calcium Phosphate Nanoparticles as an Adjuvant. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.787635"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1468-1293.2006.00393.x","article-title":"Fulminant toxoplasmosis causing fatal pneumonitis and myocarditis","volume":"7","author":"Eza","year":"2006","journal-title":"HIV Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00059-14","article-title":"Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5","volume":"21","author":"Zhang","year":"2014","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/parasite\/2020021","article-title":"Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice","volume":"27","author":"Zhu","year":"2020","journal-title":"Parasite"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yu, Z., Lu, Y., Cao, W., Aleem, M.T., Liu, J., Luo, J., Yan, R., Xu, L., Song, X., and Li, X. (2021). Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13101582"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.20160340","article-title":"Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-\u03b3-mediated host defenses","volume":"213","author":"Gay","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/s41467-022-31720-7","article-title":"The intrinsically disordered protein TgIST from Toxoplasma gondii inhibits STAT1 signaling by blocking cofactor recruitment","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1586\/erv.11.21","article-title":"Trends in vaccine adjuvants","volume":"10","author":"Schijns","year":"2011","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-13-2729","article-title":"Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity","volume":"74","author":"Villarreal","year":"2014","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.actbio.2019.05.043","article-title":"Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy","volume":"94","author":"Tran","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/hgtb.2019.013","article-title":"TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer","volume":"30","author":"Butterfield","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"948540","DOI":"10.1155\/2015\/948540","article-title":"Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1","volume":"2015","author":"Hilbert","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","first-page":"7983217","article-title":"Targeting of Immune Cells by Dual TLR2\/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice","volume":"2017","author":"Wangorsch","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2004.04.022","article-title":"Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep","volume":"22","author":"Stanley","year":"2004","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0141-9838.2004.00684.x","article-title":"CpG-containing ODN has a limited role in the protection against Toxoplasma gondii","volume":"26","author":"Saavedra","year":"2004","journal-title":"Parasite Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mayoral, J., Shamamian, P., and Weiss, L.M. (2020). In Vitro Characterization of Protein Effector Export in the Bradyzoite Stage of Toxoplasma gondii. mBio, 11.","DOI":"10.1128\/mBio.00046-20"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/fmb-2016-0146","article-title":"Synthetic parasites: A successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice","volume":"12","author":"Ducournau","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: Composition, biogenesis and function","volume":"2","author":"Zitvogel","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.171.8.4320","article-title":"Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses","volume":"171","author":"Betts","year":"2003","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41467-024-44830-1","article-title":"Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models","volume":"15","author":"Guimaraes","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2202269","DOI":"10.1080\/22221751.2023.2202269","article-title":"Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants","volume":"12","author":"Fan","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vicidomini, C., Borbone, N., Roviello, V., Roviello, G.N., and Oliviero, G. (2023). Summary of the Current Status of DNA Vaccination for Alzheimer Disease. Vaccines, 11.","DOI":"10.3390\/vaccines11111706"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_31","first-page":"1163","article-title":"Pathogeny and immunological control of toxoplasmosis","volume":"25","author":"Derouin","year":"1992","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.179.2.1113","article-title":"The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection","volume":"179","author":"Kemball","year":"2007","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.4049\/jimmunol.162.9.5449","article-title":"Augmentation of the CD8+ T cell response by IFN-gamma in IL-12-deficient mice during Toxoplasma gondii infection","volume":"162","author":"Ely","year":"1999","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.143.6.2045","article-title":"Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice","volume":"143","author":"Suzuki","year":"1989","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/IAI.70.5.2368-2374.2002","article-title":"Dendritic cells as effector cells: Gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication","volume":"70","author":"Aline","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s004300050086","article-title":"Inducible anti-parasitic effector mechanisms in human uroepithelial cells: Tryptophan degradation vs. NO production","volume":"187","author":"Posdziech","year":"1999","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/iai.64.10.4188-4196.1996","article-title":"Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells","volume":"64","author":"Nagineni","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_39","first-page":"827","article-title":"Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation","volume":"75","author":"Rang","year":"1996","journal-title":"Lab. Investig. A J. Tech. Methods Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/IAI.72.3.1257-1264.2004","article-title":"STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection","volume":"72","author":"Gavrilescu","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4049\/jimmunol.172.1.457","article-title":"STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis","volume":"172","author":"Lieberman","year":"2004","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.parint.2016.05.012","article-title":"A host cell membrane microdomain is a critical factor for organelle discharge by Toxoplasma gondii","volume":"65","author":"Tahara","year":"2016","journal-title":"Parasitol. Int."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Xu, Y., Hong, L., Zhou, C., and Chen, J. (2021). Immunization With a DNA Vaccine Encoding the Toxoplasma gondii\u2019 s GRA39 Prolongs Survival and Reduce Brain Cyst Formation in a Murine Model. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.630682"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jeu.12639","article-title":"The Molecular Characterization and Immunity Identification of Rhoptry Protein 22 of Toxoplasma gondii as a DNA Vaccine Candidate Against Toxoplasmosis","volume":"66","author":"Zhang","year":"2019","journal-title":"J. Eukaryot. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.4049\/jimmunol.168.10.4907","article-title":"IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines","volume":"168","author":"Cho","year":"2002","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1021\/acsami.7b14004","article-title":"Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses","volume":"10","author":"Li","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/577\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:48:33Z","timestamp":1760107713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["vaccines12060577"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12060577","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2024,5,25]]}}}